The Trium Group Helps Scientific Organization Clarify Its Role, Path Forward

Elite strategy consultancy supports global pharmaceutical division transformation for increased customer orientation
March 10, 2011 - PRLog -- SAN FRANCISCO—The Trium Group, the boutique management consulting firm that specializes in organizational transformation and strategy execution, is deepening its work helping one of the world’s largest pharmaceutical companies transform for increased customer orientation.

After a long engagement turning the commercial organization’s focus outward, Trium is now partnering with the company’s scientific leaders to clarify their function’s role in delivering enhanced customer experience—for both patients and customers—and creating a path that brings that role to life.

Trium’s work will furthermore include helping the function’s senior executives, many of whom are scientists and medical doctors turned business chiefs, enhance their leadership approach and capabilities in support of this transformation.

For purposes of confidentiality, Trium at this time will not disclose the client’s name nor details that would identify it.

“This world-class organization has a very compelling and game-changing vision for the future, and yet the path between the current-state and end-state is unclear,” said Andrew Blum, Trium founder and Managing Partner. “The result: organizational confusion around varied interpretations, leading to operational complexity, inefficiency, and ongoing risk some or all stakeholders will unintentionally veer off course.”

“We commend the organization’s leadership for recognizing the need to address their condition head-on, and for doing so now rather than ignoring it or hoping it will cure itself,” Blum added.

The global pharmaceutical industry today faces an array of challenges including a changing landscape in which leading players must serve a broader set of customers with increasingly specific needs, evolving regulations and health practices around the world, and rising costs for developing new blockbuster drugs.

This company also anticipates a significant revenue decline in the near future due to patent expirations and a dwindling pipeline of innovation to fill the gap. And like many other organizations, different divisions and functions are aligned around a single direction but lack a set of common goals and metrics to help keep them on the same track.

Trium Partner Shani Harmon is leading the engagement with a close-knit team of Trium consultants.

“The challenge for this organization is a common one,” said Harmon. “Its own proud history of excellence and success makes it very difficult to abandon its old success strategies. Unfortunately, with the context changing as fast as it is today, those old approaches will no longer yield the same results.”

“It’s great to work with an organization tackling this dilemma directly while so many others are hoping that the reality will just plain go away,” she added.

# # #

The Trium Group is a boutique management consulting firm that helps leaders align, equip and mobilize their organizations to solve complex business problems and execute multi-dimensional strategies. The firm specializes in large-scale transformation, new business and operating model development, roadmapping restructuring and turnarounds, and the capability-building and culture change that must accompany each of these efforts. Trium clients have included such renowned companies as AXA, Barclays Global Investors, Cisco, Gap Inc., Genentech, McKesson, Nokia and SAP. Founded in 1998, Trium is headquartered in San Francisco, CA. For more information, please visit http://www.triumgroup.com.
End



Like PRLog?
9K2K1K
Click to Share